Wave life sciences to present at the guggenheim genomic medicines and rare disease days

Cambridge, mass., march 29, 2023 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in an analyst-led fireside chat at the guggenheim genomic medicines and rare disease days in new york city on monday, april 3, 2023 at 2:10 p.m. et.
WVE Ratings Summary
WVE Quant Ranking